Join us Wed. 11/11 as our Assoc. Dir. of R&D, Jon Zawistowski Ph.D. presents @ Ilumina's Single-Cell Sequencing Virtual Symposium. Jon will share insights into PTA exposed resistance mechanisms to targeted therapeutics in #singlecells! https://t.co/sPr5Nto6Bp @illumina
In case anyone is still wondering what the future of pharma will be:
New Genentech CSO: Aviv Regev, Computational Biologist from the Broad
New Merck President & CSO: Dean Li, @RecursionPharma cofounder & board director
The big guys are waking up and taking note
Attending @SynBioBeta 2020 tomorrow? Celldom is a finalist in the Startup Draft from 2:15-3:00PM PT on Tuesday September 29. Come and meet Zach, Ben, and Kris. They'll be sharing investment, partnership, and early platform access opportunities. #SynBioBeta2020
Learn how the utilization of multi-omics plays a role in the research efforts from leaders in the field. This webinar series includes speakers from @Harvard, @IcahnMountSinai, & St. Thomas.
Watch here: https://t.co/GDDUxKIV4q
Interested in early platform access or investing in Celldom? We're featured in the @SynBioBeta Start Up Bio Draft Presentations @ Tue Sep 29, 2020 2:15pm - 3pm (PDT). Our founders will be on live chat to answer your questions! #synbiobeta2020#automatebiology#SingleCell
@surt_lab With Celldom, biologists will capture holistic cell function w/ live biology phenotyping (Up to a week) & high-res RNAseq at scale. Automated live imaging of cells in pre-barcoded compartments - library prep on chip when ready for gene expression; targeted or full chip seq.
Illumina Accelerator has selected seven early-stage companies to join its first global cohort of breakthrough genomics startups in Cambridge, UK, and the San Francisco Bay Area.
Learn more: https://t.co/Zw4f5xYuiL
On Friday, June 26 at 3:00 pm EST, I will be joined by @genome_gov Clinical Director @BenjaminSolomo2 to answer your questions about genomic medicine! You can also learn more about the NHGRI Clinical Research Program. Mark your calendar and get your questions ready!
Celldom helps our AI discovery customers create highly structured, cell-based disease models combining live biology & high resolution genomics to train in silico models with dense information acquired at scale with precision. Meet us this week #BIODigital to learn more!
@DukeU checks in with Celldom cofounder and CTO, Dr. Ben Yellen, about technology driven impact at the intersection of #cellbiology and #genomics https://t.co/YOLIZtVZEt
BioSkryb Covid-19 tests have been validated and are waiting on FDA paperwork. We're excited to get them out there on the front lines to help make testing quick and easily accessible.
#coronavirus#covid19#covid19testing https://t.co/phwxXyIMba
We're live! Join our #synbiobetalive for the latest developments from the #syntheticbiology industry, and these in-depth conversations: https://t.co/odTInPEELR #synbio
Come meet our CEO, Zach Forbes at poster #311 at #AGBT2020 tonight. He can show you how Celldom is making #singlecell multimodal-omics scalable and easy.
Made it to #AGBT2020? Be sure to drop by our poster #311 to learn how Celldom is merging cell biology with genomics to bring you highly structured #singlecell data that simply doesn’t exist today.
Join @Illumina and Distinguished Scientist @Genomics_Guy Tuesday at 1pm for the #AGBT20 Silver Sponsorship Workshop: Transforming the Future of Genomics Together.
Click here to learn more: https://t.co/JE334dFMCk
I’m not going to be at #AGBT20 this year, but if you want to learn more about @CelldomInc single cell technology, visit our CEO, Zach Forbes at poster #311.